Quarterly Result21 May 2026, 08:31 pm
Rekvina Labs: FY26 Standalone Audited Results Approved
AI Summary
Rekvina Laboratories Ltd has announced the approval of its standalone audited financial results for the quarter and year ended March 31, 2026, along with the statement of assets, liabilities, and cash flow statement for the same period. The board of directors approved these results in a meeting held on May 21, 2026, which commenced at 6:30 PM and concluded at 7:55 PM. The company operates in a single reportable business segment in India and the board did not recommend any dividend for the financial year ended March 31, 2026.
Key Highlights
- Standalone audited financial results for FY26 approved.
- Independent Audit Report submitted by Statutory Auditors.
- No dividend recommended for the financial year ended March 31, 2026.
- Board approved execution of share exchange.
Price Impact
More from VINRKLB